Account Sales Representative (ASR)

Position Overview

• Location Type: Field (Travel within Region)
• Job Type: Full-time
• Salary: Not Specified

The Account Sales Representative (ASR) plays a key supporting role within the regional sales team, assisting in the management and growth of accounts across the entire region. This individual will support field sales representatives, provide exceptional customer support, and help maintain strong client relationships. The Account Sales Representative will also provide coverage in open territories, ensuring continuity of service and sales activity. This is a field sales position and reports to a Regional Manager - Prenatal.

Responsibilities

• Provide regional assistance by supporting the daily needs of the sales team across the assigned territory.
• Maintain and strengthen relationships with existing clients.
• Provide coverage in open territories, ensuring continuity of service and sales activity.
• Support field sales representatives with administrative tasks and logistical support.
• Assist with account management and sales forecasting.

Requirements

• Not Specified

Company Information

BillionToOne is a next-generation molecular diagnostics company dedicated to developing powerful and accurate diagnostic tests that are accessible to all. Our innovative QCT molecular counting technology significantly enhances the resolution of disease detection using cell-free DNA by over a thousandfold. This groundbreaking technology is integral to our product offerings, including one of our flagship products, Unity Complete™, the only non-invasive prenatal screen capable of assessing fetal risk for both common recessive conditions and aneuploidies from a single maternal blood sample. Leveraging the same molecular counting technology, we've expanded our impact into oncology in 2023 with a pioneering liquid biopsy test, Northstar, that combines treatment selection with monitoring. To date, over 500,000 patients have benefited from our innovative and precise diagnostic tests, and our Annual Recurring Revenue (ARR) has grown from $0 to $125 million in the last ~4 years.

BillionToOne has successfully raised close to $400 million in funding, with a notable $130 million Series D round completed in June 2024, resulting in a company valuation of over $1 billion. This funding has come from prestigious global institutional investors, including Hummingbird, Adams Street Partners, Neuberger Berman, Baillie Gifford, and Premji Invest. BillionToOne has recently been recognized by Forbes as one of America's Best Startup Employers for 2024, highlighting the company's exceptional work environment and commitment to innovation.

Headquartered in Menlo Park, California, with an additional facility in Union City, California, BillionToOne remains at the forefront of significant advances in molecular diagnostics, evidenced by the recent announcement of clinical outcomes data for its Unity Fetal Risk Screen and new advancements in cancer diagnostics. For more detailed information about BillionToOne and its groundbreaking work, please visit our website at www.billiontoone.com.